LSD1 can downregulate the Wnt pathway antagonists APC2 and DKK1 through demethylation in thyroid cancer, thus inhibiting APC2 transcription and activating the HIF-1α/DKK1 axis to regulate cancer progression (Zhang W. et al., 2022). Here, KDM1A is linked to cancer.